Microfluidic cDEP Separation for High-Throughput Cell Assays
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining cellular response to agents or treatments are inefficient, particularly in drug development and patient diagnosis, due to the need for high-throughput screening devices that can effectively separate and analyze cellular subpopulations within tumor tissues.
Innovation Solution
A microfluidic contactless dielectrophoretic (cDEP) separation and assay system that includes a cDEP device with insulating pillars to trap cells based on bioelectric potential, a microfluidic concentrator to transfer cells to uncured hydrogel, and an assay chamber for rapid exposure to agents, allowing for the measurement of cellular responses.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional centrifugation methods are used for cell separation, then cell separation can be achieved, but the process becomes cumbersome and time-consuming
Solution Approach 1:
The patent replaces the mechanical centrifugation system with a dielectrophoretic field-based separation system. The cDEP device uses non-uniform electric fields to exert dielectrophoretic forces on cells, enabling separation based on cellular dielectric properties without mechanical rotation or centrifugal forces, thus eliminating the cumbersome centrifugation steps while maintaining separation capability
Solution Approach 2:
The invention changes the separation parameter from mechanical force (centrifugal acceleration) to electrical field parameter (dielectrophoretic force). By applying AC electric fields at specific frequencies, the system exploits differences in cellular dielectric properties to achieve separation, fundamentally changing the physical basis of separation from mechanical to electrical parameter control
2Productivity
If high-throughput screening is implemented, then more cellular subpopulations can be analyzed, but device complexity increases
Solution Approach 1:
The device is segmented into functionally independent modules: the cDEP separation chamber with insulating pillars for cell sorting, the hydrogel transfer chamber for maintaining cell viability, and the assay chamber for high-throughput screening. Each module performs a specific function, allowing complex high-throughput screening to be achieved through coordinated simple modular operations rather than a single complex device
Solution Approach 2:
The microfluidic device integrates multiple functions into a single platform: dielectrophoretic separation, hydrogel transfer, cell culture, and drug screening. This multi-functional integration enables high-throughput screening of cellular subpopulations without requiring multiple separate devices, actually reducing overall system complexity while increasing throughput
3Measurement precision
If cells are separated based on morphological features, then visual identification is possible, but measurement precision is limited
Solution Approach 1:
The patent replaces visual/morphological detection with electrical property-based detection using dielectrophoresis. By measuring cellular dielectric properties through dielectrophoretic response to AC electric fields, the system achieves more precise cellular characterization than visual methods, as electrical properties provide quantitative metrics for cell identification and sorting
Solution Approach 2:
The invention changes the detection parameter from morphological features (visual inspection) to electrical properties (dielectric constant, conductivity). This parameter change enables more precise measurement of cellular characteristics through electrical impedance and dielectrophoretic response measurements, providing objective quantitative data rather than subjective visual assessment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables high-throughput separation and analysis of cellular subpopulations, improving chemotherapy selection by allowing for the testing of morphologically unique cells based on electrical polarizability and providing data for optimized treatment regimens, while maintaining cell viability and avoiding cumbersome centrifugation steps.
Implementation Method 1
microfluidic contactless dielectrophoretic (cDEP) separation and assay system
Implementation Method 2
separation and analysis of cellular subpopulations based on their bioelectric potential
Data Source
AI summary
Described herein are aspects of a microfluidic separation and assay system that can include a microfluidic contactless dielectrophoretic (cDEP) device, a microfluidic concentrator, and a microfluidic assay chamber. In some aspects, microfluidic separation and assay system can be included on a single microfluidic chip. Also described herein are methods of using the microfluidic separation and assay system described herein.